Kacy A Church, MD | UniHealth

Offices

1 location · Sutter Bay Medical Foundation · 3,783 clinicians in this group

Looking this up.

Hospitals listed: Mills-Peninsula Medical Center. That is not proof they admit you there this week.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Church’s office at (650) 696-5400 to ask if they take your plan before you enroll.

California Medical Board record

Licence A135238 · Current

Licensed to practise in California · since 2015 · expires 2028-08-31 · University of Hawaii School of Medicine.

Matched on the licence number without its letter prefix; check the name before relying on it.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend it
Overall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025

See every measure and the patient survey for Peninsula Medical Center

Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Sort by

Every scored measure at Peninsula Medical Center

Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections	0.139	Better	Oct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections	0.242	Better	Oct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths	1.21 (0.27 to 2.15) · 1,258 cases	No different	Jul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths	0.81 (0.51 to 1.1)	No different	Jul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths	155.44 (112.67 to 198.21) · 90 cases	No different	Jul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths	2.5 · 32 cases	None	Jul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths	7.1 · 82 cases	None	Jul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths	10 · 188 cases	None	Jul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths	9 · 473 cases	None	Jul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths	14.8 · 342 cases	None	Jul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths	9.4 · 485 cases	None	Jul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths	2.9 · 3,730 cases	None	Jul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths	0.2 (0 to 0.4) · 6,904 cases	No different	Jul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths	0.21 (0.02 to 0.4) · 7,052 cases	No different	Jul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths	3.41 (1.43 to 5.39) · 1,695 cases	No different	Jul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths	1.72 (0.17 to 3.28) · 665 cases	No different	Jul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths	2.11 (0.66 to 3.56) · 1,545 cases	No different	Jul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths	7.1 (1.3 to 12.9) · 670 cases	No different	Jul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths	5.96 (2.63 to 9.29) · 653 cases	No different	Jul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths	1.61 (0.15 to 3.08) · 418 cases	No different	Jul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths	0.14 (0 to 0.78) · 5,539 cases	No different	Jul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths	3.7 · 192 cases	None	Apr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections	0.215	No different	Oct 2024 – Sep 2025
MRSA BacteremiaInfections	0.263	No different	Oct 2024 – Sep 2025
SSI - Colon SurgeryInfections	0.74	No different	Oct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits	14.3 · 300 cases	None	Jul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits	19 · 702 cases	None	Jul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits	1.2 · 207 cases	None	Jul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits	-13.6 · 531 cases	None	Jul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits	24.3 · 343 cases	None	Jul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits	18.1 · 449 cases	None	Jul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits	4.5 (2.8 to 7) · 85 cases	No different	Jan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits	9.6 (6.7 to 13.7) · 85 cases	No different	Jan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits	5.7 · 189 cases	None	Jul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits	11 · 45 cases	None	Jul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits	20.6 · 117 cases	None	Jul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits	13 (9.7 to 17.2) · 584 cases	No different	Jan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits	0.9 (0.7 to 1.2) · 764 cases	No different	Jan 2024 – Dec 2024

What patients said (523 patients answered, 27% of those asked)

Sort by

Patient survey stars by topic at Peninsula Medical Center

Cleanliness	4
Nurse communication	4
Doctor communication	4
Communication about medicines	3
Discharge information	4
Overall hospital rating	4
Quietness	3
Recommend hospital	5

Sort by

Share of patients giving the best answer at Peninsula Medical Center

Room was "always" clean	76%
Nurses "always" communicated well	81%
Doctors "always" communicated well	80%
Staff "always" explained	58%
Yes, staff "did" give patients this information	89%
Yes, staff "did" give patients information about help after discharge	87%
Doctors "always" explained things so they could understand	74%
Doctors "always" listened carefully	79%
Doctors "always" treated them with courtesy and respect	87%
Patients who gave a rating of "9" or "10" (high)	75%
Staff "always" explained new medications	72%
Nurses "always" explained things so they could understand	77%
Nurses "always" listened carefully	79%
Nurses "always" treated them with courtesy and respect	88%
"Always" quiet at night	54%
"YES", patients would definitely recommend the hospital	78%
Staff "always" explained possible side effects	44%
Yes, staff "did" give patients information about possible symptoms	90%

Original Medicare doctor bills

$109,278

Medicare paid this office $109,278 for 427 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Sort by

Largest Original Medicare bills

Return visit (30+ min)	296	$62,024	$109
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes	64	$14,347	$69
Initial hospital care with moderate level of medical decision making at least 75 minutes	43	$7,338	$153
New patient visit (45+ min)	52	$6,740	$130
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	283	$5,863	$14

See all 8 services

Sort by

Every Original Medicare service billed

Return visit (30+ min)	296	$62,024	$109
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes	64	$14,347	$69
Initial hospital care with moderate level of medical decision making at least 75 minutes	43	$7,338	$153
New patient visit (45+ min)	52	$6,740	$130
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	283	$5,863	$14
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report	82	$5,027	$30
Short return visit (20+ min)	34	$2,630	$75
Hemoglobin a1c level	12	$114	$10

Who their Medicare patients are

427 Original Medicare patients in 2024. Average age 75 · Under 65 3% · 85 and older 12% · Women 63% · Also on Medicaid 10% · Health risk score 1.54. Above the middle of the specialty; the typical endocrinology clinician is at 1.46.

Conditions among them: High blood pressure 75% · Diabetes 66% · Chronic kidney disease 45% · Coronary heart disease 29% · Heart failure 22% · Atrial fibrillation 22% · Cancer 19% · Depression 16% · COPD 11% · Dementia 8% · Stroke 8%.

The office billed $419,103, Medicare allowed $151,325 and paid $109,278; for 1,556 services of 20 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Sort by

Original Medicare by year

2024	427	1,556	75	1.54	$419,103	$109,278
2023	396	1,120	76	1.68	$355,528	$98,515
2022	368	1,172	75	1.84	$359,009	$99,701
2021	304	982	75	1.65	$294,718	$88,852
2020	213	515	74	1.90	$143,062	$40,280
2019	237	741	73	2.03	$229,937	$66,492
2018	186	587	72	1.90	$159,049	$45,726

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 8 services

Sort by

Original Medicare services billed in 2023

Return visit (30+ min)	268	$57,328	$108
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes	59	$11,090	$72
New patient visit (45+ min)	62	$9,307	$150
Initial hospital care with moderate level of medical decision making at least 75 minutes	35	$5,677	$149
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report	70	$4,851	$30
Long return visit (40+ min)	25	$4,325	$144
Short return visit (20+ min)	17	$1,571	$79
Hemoglobin a1c level	69	$838	$10

2022: 8 services

Sort by

Original Medicare services billed in 2022

Return visit (30+ min)	240	$55,555	$107
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes	68	$10,865	$62
New patient visit (45+ min)	71	$9,551	$135
Initial hospital care with moderate level of medical decision making at least 75 minutes	38	$7,185	$156
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report	57	$4,015	$30
Long return visit (40+ min)	19	$3,924	$163
Short return visit (20+ min)	20	$1,812	$76
Hemoglobin a1c level	80	$1,171	$10

2021: 7 services

Sort by

Original Medicare services billed in 2021

Return visit (30+ min)	176	$40,595	$114
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes	59	$14,792	$65
New patient visit (45+ min)	94	$14,041	$149
Initial hospital care with moderate level of medical decision making at least 75 minutes	37	$6,742	$182
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report	45	$2,810	$31
Telephone medical discussion with physician, 21-30 minutes	14	$1,937	$92
Hemoglobin a1c level	62	$825	$10

2020: 9 services

Sort by

Original Medicare services billed in 2020

Return visit (30+ min)	80	$10,590	$85
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes	38	$7,455	$68
Short return visit (20+ min)	53	$4,295	$57
New patient visit (45+ min)	35	$4,030	$115
Initial hospital care with moderate level of medical decision making at least 75 minutes	20	$3,600	$180
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes	14	$1,437	$96
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report	30	$1,259	$29
New patient visit (30+ min)	12	$1,146	$95
Telephone medical discussion with physician, 11-20 minutes	11	$1,111	$69

2019: 8 services

Sort by

Original Medicare services billed in 2019

Return visit (30+ min)	91	$16,692	$94
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes	51	$16,095	$64
Short return visit (20+ min)	62	$7,206	$62
New patient visit (45+ min)	49	$6,970	$142
Initial hospital care with moderate level of medical decision making at least 75 minutes	32	$5,375	$168
New patient visit (30+ min)	32	$2,787	$87
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes	23	$2,391	$89
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report	11	$350	$32

2018: 6 services

Sort by

Original Medicare services billed in 2018

Return visit (30+ min)	65	$11,925	$95
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes	48	$9,859	$63
New patient visit (45+ min)	47	$6,006	$128
Short return visit (20+ min)	46	$4,595	$68
Initial hospital care with moderate level of medical decision making at least 75 minutes	26	$4,351	$167
New patient visit (30+ min)	42	$3,507	$84

Medicaid work

$1,220 in 2024

Medicaid paid $1,220 for 22 billed services this clinician did in 2024, up to 13 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Sort by

Largest Medicaid services in 2024

SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES	22	$1,220

Sort by

Medicaid work by year

2024	22	1	13	$1,220
2023	86	2	13	$3,061
2022	41	2	13	$731
2021	14	1	14	$263

See the largest Medicaid services in earlier years

2023

Sort by

Largest Medicaid services in 2023

SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES	73	$2,820
Return visit (30+ min)	13	$241

2022

Sort by

Largest Medicaid services in 2022

SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES	28	$590
Return visit (30+ min)	13	$141

2021

Sort by

Largest Medicaid services in 2021

Return visit (30+ min)	14	$263

Drugs they prescribed that Part D paid

$2,202,344

Pharmacies billed $2,202,344 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 3,757) in 2024. At or below the middle of the specialty; the typical endocrinology clinician is at 0%.

1,658 generic and 1,823 brand-name prescriptions · $2,202,344 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Sort by

Largest Part D drug costs

Ozempic	283	$540,407	$1,910
Trulicity	198	$408,994	$2,066
Jardiance	258	$383,296	$1,486
Mounjaro	99	$137,889	$1,393
Farxiga	104	$121,899	$1,172

See all 53 drugs

Sort by

Every Part D drug this clinician prescribed

Ozempic	283	$540,407	$1,910
Trulicity	198	$408,994	$2,066
Jardiance	258	$383,296	$1,486
Mounjaro	99	$137,889	$1,393
Farxiga	104	$121,899	$1,172
Rybelsus	30	$61,400	$2,047
Tymlos	18	$47,614	$2,645
Omnipod 5 Dexg7g6 Pods (Gen 5)	39	$43,115	$1,106
Synjardy Xr	34	$41,580	$1,223
Humalog Kwikpen U-200	19	$32,526	$1,712
Januvia	20	$27,981	$1,399
Humalog Kwikpen U-100	70	$21,898	$313
Lantus Solostar	132	$16,207	$123
Nano 2nd Gen Pen Needle	135	$16,185	$120
Tresiba Flextouch U-200	24	$15,773	$657
Tresiba Flextouch U-100	29	$15,285	$527
Cinacalcet	26	$13,522	$520
Insulin Lispro Kwikpen U-100	34	$13,483	$397
Tradjenta	11	$13,449	$1,223
Toujeo Solostar	16	$11,887	$743
Dapagliflozin	14	$8,700	$621
Synthroid	81	$7,983	$99
Insulin Aspart Flexpen	16	$7,432	$465
Humalog	27	$7,114	$263
Basaglar Kwikpen U-100	11	$6,154	$559
Novolog Flexpen	22	$5,321	$242
Metformin Hcl Er	249	$4,627	$19
Metformin	311	$3,622	$12
Repaglinide	41	$3,516	$86
Cabergoline	14	$3,387	$242
Levothyroxine	203	$3,123	$15
Humulin 70/30 Kwikpen	23	$2,813	$122
Ultra-Fine Nano Pen Needle	16	$1,907	$119
Alendronate	155	$1,870	$12
Insulin Lispro	13	$1,637	$126
Atorvastatin	118	$1,629	$14
Ultra-Fine Mini Pen Needle	15	$1,486	$99
Pioglitazone	77	$1,465	$19
Lantus	11	$1,442	$131
Nateglinide	15	$1,424	$95
Insulin Glargine-Yfgn	17	$1,268	$75
Hydrocortisone	17	$1,173	$69
Methimazole	55	$785	$14
Rosuvastatin	39	$727	$19
Irbesartan	18	$611	$34
Glipizide	62	$547	$9
Amlodipine Besylate	39	$450	$12
Lisinopril	32	$442	$14
Pravastatin	14	$350	$25
Losartan	29	$313	$11
Hydrochlorothiazide	14	$150	$11
Glimepiride	18	$143	$8
Simvastatin	15	$130	$9

Year by year

Sort by

Part D prescribing by year

2024	3,757	480	0% (0)	49%	$2,202,344
2023	3,205	414	0% (0)	48%	$2,086,915
2022	2,804	389	0% (0)	51%	$1,762,311
2021	2,139	322	0% (0)	50%	$1,206,462
2020	1,556	256	0% (0)	48%	$845,522
2019	1,469	234	0% (0)	50%	$775,843
2018	648	128	0% (0)	53%	$263,770
2016	20	None	0% (0)	None	$701
2015	254	115	5% (13)	24%	$9,949
2014	362	110	8% (28)	12%	$12,007
2013	334	43	10% (33)	None	$14,103

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 49 drugs

Sort by

Part D drugs prescribed in 2023

Trulicity	320	$629,019	$1,966
Jardiance	184	$301,363	$1,638
Ozempic	149	$296,881	$1,992
Farxiga	105	$143,136	$1,363
Humalog Kwikpen U-100	68	$65,116	$958
Lantus Solostar	107	$60,151	$562
Humalog	37	$37,406	$1,011
Januvia	25	$30,473	$1,219
Humalog Kwikpen U-200	13	$30,423	$2,340
Omnipod 5 G6 Pods (Gen 5)	24	$29,078	$1,212
Mounjaro	21	$28,737	$1,368
Victoza 3-Pak	18	$25,476	$1,415
Novolog Flexpen	18	$20,119	$1,118
Toujeo Max Solostar	12	$17,649	$1,471
Tresiba Flextouch U-200	21	$15,411	$734
Cinacalcet	24	$14,603	$608
Tradjenta	11	$14,140	$1,285
Nano 2nd Gen Pen Needle	101	$12,671	$125
Insulin Lispro Kwikpen U-100	26	$10,864	$418
Levemir Flexpen	12	$8,424	$702
Humulin 70/30 Kwikpen	18	$7,565	$420
Insulin Aspart Flexpen	13	$6,807	$524
Tresiba Flextouch U-100	13	$6,615	$509
Synthroid	66	$6,176	$94
Metformin Hcl Er	207	$5,023	$24
Metformin	246	$4,624	$19
Levothyroxine	189	$4,018	$21
Ultra-Fine Nano Pen Needle	28	$2,544	$91
Ultra-Fine Mini Pen Needle	22	$2,331	$106
Insulin Glargine-Yfgn	16	$2,200	$137
Repaglinide	19	$2,164	$114
Alendronate	141	$2,009	$14
Atorvastatin	101	$1,866	$18
Glipizide	79	$1,743	$22
Nateglinide	12	$1,573	$131
Pioglitazone	49	$1,430	$29
Droplet Pen Needle	11	$1,289	$117
Cabergoline	11	$972	$88
Methimazole	59	$964	$16
Hydrocortisone	11	$930	$85
Losartan	32	$846	$26
Glipizide Er	23	$707	$31
Rosuvastatin	26	$508	$20
Pravastatin	20	$499	$25
Unifine Pentips	13	$435	$33
Lisinopril	36	$402	$11
Simvastatin	17	$399	$23
Amlodipine Besylate	29	$296	$10
Glimepiride	13	$224	$17

2022: 45 drugs

Sort by

Part D drugs prescribed in 2022

Trulicity	335	$579,742	$1,731
Jardiance	173	$263,155	$1,521
Ozempic	109	$229,831	$2,109
Humalog Kwikpen U-100	84	$82,105	$977
Lantus Solostar	140	$81,794	$584
Novolog Flexpen	45	$67,251	$1,494
Farxiga	43	$62,192	$1,446
Victoza 3-Pak	33	$56,633	$1,716
Januvia	24	$30,470	$1,270
Humalog	18	$15,336	$852
Cinacalcet	16	$14,427	$902
Tresiba Flextouch U-200	16	$12,046	$753
Nano 2nd Gen Pen Needle	78	$10,352	$133
Toujeo Solostar	16	$10,227	$639
Insulin Aspart Flexpen	11	$6,406	$582
Lantus	15	$6,307	$420
Insulin Lispro Kwikpen U-100	28	$5,302	$189
Synthroid	63	$5,052	$80
Basaglar Kwikpen U-100	19	$4,697	$247
Insulin Lispro	19	$4,132	$217
Humulin 70/30 Kwikpen	13	$3,959	$305
Metformin Hcl Er	185	$3,773	$20
Levothyroxine	153	$3,723	$24
Metformin	236	$3,292	$14
Repaglinide	21	$2,706	$129
Insulin Lispro Protamine Mix	13	$2,138	$164
Ultra-Fine Nano Pen Needle	22	$2,059	$94
Droplet Pen Needle	18	$1,548	$86
Nateglinide	13	$1,493	$115
Alendronate	91	$1,429	$16
Atorvastatin	77	$1,239	$16
Glipizide	63	$1,009	$16
Testosterone Cypionate	22	$992	$45
Novofine Autocover	11	$942	$86
Pioglitazone	35	$859	$25
Methimazole	52	$764	$15
Rosuvastatin	17	$580	$34
Pravastatin	19	$465	$24
Prednisone	11	$383	$35
Glipizide Er	11	$236	$21
Amlodipine Besylate	24	$236	$10
Losartan	12	$231	$19
Lisinopril	25	$169	$7
Simvastatin	18	$160	$9
Glimepiride	12	$43	$4

2021: 34 drugs

Sort by

Part D drugs prescribed in 2021

Trulicity	257	$403,089	$1,568
Jardiance	135	$188,269	$1,395
Ozempic	76	$120,308	$1,583
Humalog Kwikpen U-100	57	$72,358	$1,269
Lantus Solostar	105	$68,139	$649
Victoza 3-Pak	30	$46,624	$1,554
Novolog Flexpen	19	$34,413	$1,811
Januvia	23	$32,637	$1,419
Toujeo Solostar	17	$13,041	$767
Insulin Lispro Kwikpen U-100	34	$12,608	$371
Farxiga	14	$11,876	$848
Nano 2nd Gen Pen Needle	69	$8,106	$117
Humulin 70/30 Kwikpen	15	$5,498	$367
Glucagon Emergency Kit	14	$4,256	$304
Novolin N	12	$4,004	$334
Basaglar Kwikpen U-100	17	$3,983	$234
Synthroid	39	$3,473	$89
Metformin Hcl Er	153	$3,335	$22
Levothyroxine	115	$3,205	$28
Ultra-Fine Nano Pen Needle	35	$2,730	$78
Metformin	198	$2,665	$13
Repaglinide	12	$1,491	$124
Atorvastatin	64	$1,101	$17
Alendronate	55	$975	$18
Pioglitazone	40	$970	$24
Glipizide	49	$588	$12
Rosuvastatin	21	$560	$27
Testosterone Cypionate	11	$415	$38
Lisinopril	26	$313	$12
Prednisone	17	$270	$16
Methimazole	18	$225	$13
Amlodipine Besylate	34	$224	$7
Losartan	12	$215	$18
Glimepiride	13	$77	$6

2020: 34 drugs

Sort by

Part D drugs prescribed in 2020

Trulicity	175	$266,598	$1,523
Victoza 3-Pak	42	$80,622	$1,920
Humalog Kwikpen U-100	51	$65,677	$1,288
Lantus Solostar	93	$64,825	$697
Jardiance	47	$53,390	$1,136
Novolog Flexpen	22	$38,753	$1,761
Ozempic	14	$23,477	$1,677
Januvia	14	$19,585	$1,399
Toujeo Solostar	31	$19,502	$629
Levemir Flextouch	17	$17,237	$1,014
Novolog Mix 70-30 Flexpen	18	$10,130	$563
Humalog	14	$8,084	$577
Insulin Lispro Kwikpen U-100	16	$7,332	$458
Ultra-Fine Nano Pen Needle	73	$6,116	$84
Humulin 70/30 Kwikpen	12	$3,792	$316
Levothyroxine	75	$2,257	$30
Metformin	148	$1,969	$13
Metformin Hcl Er	79	$1,928	$24
Rosuvastatin	29	$1,687	$58
Synthroid	16	$1,679	$105
Liothyronine	13	$1,415	$109
Repaglinide	17	$1,333	$78
Atorvastatin	55	$1,011	$18
Nateglinide	12	$969	$81
Pioglitazone	32	$825	$26
Hydrocortisone	12	$697	$58
Alendronate	49	$696	$14
Glipizide	44	$562	$13
Testosterone Cypionate	12	$311	$26
Methimazole	20	$303	$15
Glipizide Er	11	$294	$27
Lisinopril	26	$231	$9
Losartan	12	$130	$11
Amlodipine Besylate	17	$96	$6

2019: 27 drugs

Sort by

Part D drugs prescribed in 2019

Trulicity	166	$206,524	$1,244
Victoza 3-Pak	61	$105,571	$1,731
Humalog Kwikpen U-100	58	$79,171	$1,365
Lantus Solostar	108	$56,614	$524
Novolog Flexpen	30	$44,756	$1,492
Jardiance	29	$40,226	$1,387
Januvia	38	$35,836	$943
Levemir Flextouch	28	$21,199	$757
Toujeo Solostar	18	$11,588	$644
Tradjenta	18	$10,128	$563
Ultra-Fine Nano Pen Needle	93	$7,908	$85
Nateglinide	15	$2,752	$183
Levothyroxine	73	$2,432	$33
Liothyronine	18	$2,229	$124
Metformin Hcl Er	57	$1,723	$30
Metformin	132	$1,639	$12
Rosuvastatin	17	$979	$58
Synthroid	13	$923	$71
Atorvastatin	42	$796	$19
Pioglitazone	19	$790	$42
Methimazole	37	$640	$17
Glipizide	29	$500	$17
Alendronate	39	$456	$12
Testosterone Cypionate	13	$353	$27
Irbesartan	11	$226	$21
Losartan	16	$166	$10
Lisinopril	16	$113	$7

2018: 17 drugs

Sort by

Part D drugs prescribed in 2018

Victoza 3-Pak	43	$50,031	$1,164
Humalog Kwikpen U-100	36	$35,611	$989
Januvia	34	$27,141	$798
Lantus Solostar	53	$23,004	$434
Novolog Flexpen	18	$20,445	$1,136
Trulicity	21	$17,924	$854
Tradjenta	16	$16,373	$1,023
Levemir Flextouch	14	$11,037	$788
Ultra-Fine Nano Pen Needle	45	$3,305	$73
Levothyroxine	44	$1,252	$28
Metformin Hcl Er	44	$729	$17
Metformin	53	$623	$12
Hydrocortisone	11	$564	$51
Glipizide	20	$251	$13
Testosterone Cypionate	11	$189	$17
Methimazole	12	$150	$13
Alendronate	12	$106	$9

2015: 6 drugs

Sort by

Part D drugs prescribed in 2015

Gabapentin	15	$555	$37
Triamcinolone Acetonide	13	$436	$34
Proair Hfa	13	$424	$33
Fluticasone Propionate	18	$388	$22
Sertraline	14	$324	$23
Metoprolol	13	$87	$7

2014: 8 drugs

Sort by

Part D drugs prescribed in 2014

Quetiapine	13	$1,894	$146
Omeprazole	13	$318	$24
Oxycodone	12	$280	$23
Prednisone	17	$272	$16
Doxycycline Monohydrate	15	$243	$16
Simvastatin	24	$222	$9
Levothyroxine	15	$209	$14
Metoprolol	20	$62	$3

2013: 8 drugs

Sort by

Part D drugs prescribed in 2013

Quetiapine	12	$2,490	$207
Promethazine	12	$687	$57
Venlafaxine Hcl Er	13	$651	$50
Oxycodone	16	$308	$19
Omeprazole	21	$233	$11
Methadone	13	$199	$15
Simvastatin	13	$162	$12
Metoprolol	15	$39	$3

Money from drug and device companies

$94 in 2025

Sort by

Industry payments by year

2025	2	2	None	$94
2021	1	1	None	$14
2019	1	1	None	$59

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Sort by

Payments by company

Sequel Med Tech	Twiist	$74	1 payment Meals for Twiist · 2025-11-04 · $74
Dexcom	Dexcom G6 Transmitter	$21	1 payment Meals for Dexcom G6 Transmitter · 2025-06-24 · $21

See all 2 published payments

Sort by

Every published payment

Sequel Med Tech	Meals · 2025-11-04	Twiist	$74
Dexcom	Meals · 2025-06-24	Dexcom G6 Transmitter	$21

See earlier years (2021, 2019)

2021: $14

Sort by

Payments by company in 2021

Amgen	None	$14	1 payment Education · 2021-10-13 · $14

2019: $59

Sort by

Payments by company in 2019

Mannkind	Afrezza	$59	1 payment Gift for Afrezza · 2019-08-08 · $59

Professional record

NPI: 1457642027
Licence: CA 135238, OR MD166044California A135238: Current · expires 2028-08-31
Trained: University of Hawaii John A. Burns School of Medicine, 2011
Group: Sutter Bay Medical Foundation
Video visits: Lists video visits
Gender: Female

More record details

Sole proprietor: No
Taxonomy: Internal medicine (207R00000X)
Mailing address: 325 Distel Cir, Los Altos, CA, 94022
NPI first listed: 2011-04-29
NPI last updated: 2020-06-22
NPI record certified: 2020-06-22

This is when the NPI record was last certified, not a medical board exam.

Extra NPI addresses: 300 Pasteur Dr Rm S025, Stanford, CA, 94305